| Name | Cvs Pharmacy # 03193 |
|---|---|
| Organization Name | Ohio Cvs Stores Llc |
| Location | 1400 Parsons Ave, Columbus, Ohio 43206 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (614) 449-9399 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of the InFuse T-10 Syringe Infuser. Specifically designed for the delivery of intermittent antibiotics and other non-rate critical intravenous doses, the Baxa InFuse T-10 Syringe Infuser frees up expensive, smart infusion pumps for more critical applications and gives nurses more time to focus on patient care.
› Verified 5 days ago
| NPI Number | 1356444186 |
| Organization Name | OHIO CVS STORES LLC |
| Doing Business As | CVS PHARMACY 03193 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1400 Parsons Ave, Columbus, OH 43206 |
| Phone Number | 614-449-9399 |
News Archive
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of the InFuse T-10 Syringe Infuser. Specifically designed for the delivery of intermittent antibiotics and other non-rate critical intravenous doses, the Baxa InFuse T-10 Syringe Infuser frees up expensive, smart infusion pumps for more critical applications and gives nurses more time to focus on patient care.
› Verified 5 days ago
News Archive
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July 22, 2014.
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of the InFuse T-10 Syringe Infuser. Specifically designed for the delivery of intermittent antibiotics and other non-rate critical intravenous doses, the Baxa InFuse T-10 Syringe Infuser frees up expensive, smart infusion pumps for more critical applications and gives nurses more time to focus on patient care.
› Verified 5 days ago
Ace Prosthetics, Inc Type: Prosthetic/Orthotic Supplier Location: 4971 Arlington Centre Blvd, Columbus, Ohio 43220 Phone: (614) 291-8325 | |
Advanced Home Medical Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6665 Huntley Rd, Columbus, Ohio 43229 Phone: (614) 433-9011 | |
Advanced Medical Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4840 W Broad St, Columbus, Ohio 43228 Phone: (614) 870-0111 | |
Aids Healthcare Foundation Type: Community/Retail Pharmacy Location: 1230 N High St, Columbus, Ohio 43201 Phone: (614) 291-2670 | |
Amc Ohio Llc, Dba Equitas Health Ph Type: Pharmacy Location: 736 E Long St, Columbus, Ohio 43203 Phone: (614) 300-2334 |